Drug-Induced Movement Disorders-Reference-Cited by-同舟云学术

Drug-Induced Movement Disorders

Published:2015-04 Issue:2 Volume:25 Page:70-77
ISSN:1940-7769
Container-title:Perspectives on Neurophysiology and Neurogenic Speech and Language Disorders
language:en
Short-container-title:Perspect Neurophysiol Neurogenic Speech Lang Disord

Author:

Lustig Amy¹,Ruiz Cesar²

Affiliation:

1. Private Speech Pathology Practice, Restorative Speech & Swallow, LLCJenkintown, PA

2. Speech-Language-Hearing Science Program, La Salle UniversityPhiladelphia, PA

Abstract

The purpose of this article is to present a general overview of the features of drug-induced movement disorders (DIMDs) comprised by Parkinsonism and extrapyramidal symptoms. Speech-language pathologists (SLPs) who work with patients presenting with these issues must have a broad understanding of the underlying disease process. This article will provide a brief introduction to the neuropathophysiology of DIMDs, a discussion of the associated symptomatology, the pharmacology implicated in causing DIMDs, and the medical management approaches currently in use.

Publisher

American Speech Language Hearing Association

Subject

General Medicine

Link

http://pubs.asha.org/doi/pdf/10.1044/nnsld25.2.70

Reference19 articles.

1. Differentiating Parkinson's disease from other Parkinsonian disorders;Alvarez M. V.;Seminars in Neurology,2007

2. Parkinson's disease: The syndrome, the pathogenesis and pathophysiology;Bartels A. L.;Cortex,2009

3. Drug-induced Parkinsonism: A review of 17 years' experience in a regional pharmacovigilance center in France;Bondon-Guitton E.;Movement Disorders,2011

4. Differentiating drug-induced Parkinsonism from Parkinson's disease: An update on non-motor symptoms and investigations;Brigo F.;Parkinsonism & Related Disorders,2014

5. Medical management of oral motor disorders: Dystonia, dyskinesia and drug-induced dystonic extrapyramidal reactions;Clark G. T.;Journal of the California Dental Association,2006